BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 36466838)

  • 1. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
    Yu S; Xiao H; Ma L; Zhang J; Zhang J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Jun; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
    ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
    Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
    Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.
    Han Y; Tian X; Zhai J; Zhang Z
    Front Cell Dev Biol; 2024; 12():1363121. PubMed ID: 38774648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
    Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
    Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies.
    Hernández ÁP; Juanes-Velasco P; Landeira-Viñuela A; Bareke H; Montalvillo E; Góngora R; Fuentes M
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
    Peng J; Li S; Ti H
    Int J Nanomedicine; 2024; 19():5895-5930. PubMed ID: 38895146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide-Based K
    Lee D; Ha J; Ahn H; Jeong SD; Jeong M; Park JH; Yun CO; Kim YC
    ACS Appl Bio Mater; 2021 Dec; 4(12):8333-8342. PubMed ID: 35005917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic Cell Death in Hematological Malignancy Therapy.
    Liu Z; Xu X; Liu K; Zhang J; Ding D; Fu R
    Adv Sci (Weinh); 2023 May; 10(13):e2207475. PubMed ID: 36815385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
    Aria H; Rezaei M
    Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.
    Amiri M; Molavi O; Sabetkam S; Jafari S; Montazersaheb S
    Cancer Cell Int; 2023 Sep; 23(1):200. PubMed ID: 37705051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.